GLAND — Gland Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapFalling Star

Annual balance sheet for Gland Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	7,533	13,252	30,058	32,427	37,628
Net Total Accounts Receivable
Net Total Receivables	5,524	6,647	7,479	12,928	10,360
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	23,575	28,463	51,236	58,521	69,008
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	10,529	11,566	12,920	16,804	17,361
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	35,235	40,860	64,961	78,336	87,775
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	5,328	3,590	5,125	5,820	7,291
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	6,616	4,398	5,928	6,760	8,188
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	28,620	36,462	59,032	71,576	79,587
Total Liabilities & Shareholders' Equity	35,235	40,860	64,961	78,336	87,775
Total Common Shares Outstanding